TipRanks
Advertisement

SASS - ETF AI Analysis

Compare

Top Page

SASS

M.D. Sass Concentrated Value ETF (SASS)

Rating:69Neutral
Price Target:
SASS, the M.D. Sass Concentrated Value ETF, has a solid overall rating, suggesting it holds a generally attractive mix of stocks with some areas to watch. Strong contributors like Ametek, Quest Diagnostics, and Clean Harbors support the fund with robust financial performance, positive earnings call sentiment, and favorable technical trends, while Amazon and Williams Co add growth and income but come with higher valuations and some cash flow concerns. On the weaker side, Primo Brands and Knight Transportation face profitability, valuation, and operational challenges, and because this is a concentrated portfolio, issues in a few holdings can have a bigger impact on the ETF’s risk and rating.
Positive Factors
Strong Top Holdings
Several of the largest positions, including Quest Diagnostics, Clean Harbors, and Welltower, have shown strong gains this year, helping support the fund’s overall results.
Broad Sector Mix
Holdings spread across industrials, health care, consumer sectors, technology, energy, financials, real estate, and materials help reduce the impact of weakness in any single industry.
Focused Value Strategy
The fund’s concentrated approach in selected value-oriented stocks allows it to fully benefit when its chosen companies perform well.
Negative Factors
Recent Weak Performance
The ETF has delivered weak results over the past month, three months, and year to date, which may concern investors looking for near-term strength.
High Concentration in Top Holdings
A relatively small number of stocks make up a large share of the portfolio, increasing the risk that problems at a few companies could significantly hurt returns.
Higher Expense Ratio
The fund’s expense ratio is on the higher side for an ETF, which means more of the investment’s returns are used to cover fees.

SASS vs. SPDR S&P 500 ETF (SPY)

SASS Summary

M.D. Sass Concentrated Value ETF (SASS) is an actively managed fund that focuses on a small group of U.S. companies the managers believe are undervalued. It doesn’t track a set index, but follows a value theme across many sectors like industrials, health care, and technology. Well-known holdings include Amazon and Capital One Financial. Investors might consider SASS if they want a focused, value-tilted fund that’s different from broad market index ETFs and aims for growth through careful stock picking. Because it holds a limited number of stocks, the ETF can be more volatile and can go up and down more than a widely diversified fund.
How much will it cost me?This ETF has an expense ratio of 0.75%, which means you’ll pay about $7.50 per year for every $1,000 you invest. That’s higher than the average ETF because it’s actively managed, paying a professional team to research and select a smaller group of value stocks they believe can outperform the market.
What would affect this ETF?This ETF could benefit if the U.S. economy stays healthy, industrial and health care companies grow profits, and investors favor value stocks, which may help its concentrated bets in names like Ametek, Henry Schein, and Amazon. On the other hand, a U.S. slowdown, rising interest rates hurting financials and real estate, or poor performance from a few large holdings could weigh heavily on returns because the fund is focused in specific sectors and a relatively small number of stocks.

SASS Top 10 Holdings

This value-focused ETF leans heavily on a handful of U.S. names, with industrial and health-care plays doing much of the heavy lifting. Clean Harbors, Quest Diagnostics, and Knight Transportation have been rising, giving the fund a solid backbone in steady, cash-generating businesses. Henry Schein and Ametek are also pulling their weight with generally positive momentum. On the flip side, Amazon has been choppy and Primo Brands is clearly lagging, acting like a small anchor on performance. Overall, it’s a concentrated U.S. value bet with selective exposure rather than broad market coverage.
Name
Company Name
Weight %
Market Value
Market Cap
Yearly Gain
Overall Rating
Amazon7.01%$5.21M$2.65T8.63%
71
Outperform
Henry Schein6.61%$4.91M$9.67B24.06%
74
Outperform
Quest Diagnostics6.19%$4.60M$27.27B34.98%
79
Outperform
Clean Harbors6.15%$4.57M$16.84B33.06%
78
Outperform
Capital One Financial5.96%$4.42M$124.65B-12.06%
71
Outperform
Knight Transportation5.69%$4.23M$10.71B61.35%
64
Neutral
Ametek5.59%$4.15M$53.23B24.18%
79
Outperform
Primo Brands5.47%$4.06M$7.66B-5.50%
57
Neutral
Welltower4.88%$3.62M$169.01B39.47%
77
Outperform
Analog Devices4.87%$3.62M$175.43B45.61%
78
Outperform

SASS Technical Analysis

Technical Analysis Sentiment
Negative
Last Price
Price Trends
50DMA
24.46
Negative
100DMA
24.47
Negative
200DMA
Market Momentum
MACD
-0.23
Positive
RSI
40.48
Neutral
STOCH
10.20
Positive
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For SASS, the sentiment is Negative. The current price of undefined is equal to the 20-day moving average (MA) of 24.20, equal to the 50-day MA of 24.46, and equal to the 200-day MA of ―, indicating a neutral trend. The MACD of -0.23 indicates Positive momentum. The RSI at 40.48 is Neutral, neither overbought nor oversold. The STOCH value of 10.20 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for SASS.

SASS Peer Comparison

Comparison Results
Name
Price
Price Target
AUM
Expense Ratio
Overall Rating
$74.84M0.75%
69
Neutral
$98.70M0.50%
73
Outperform
$92.26M0.30%
68
Neutral
$45.50M0.87%
59
Neutral
$44.91M0.45%
69
Neutral
$2.97M0.45%
70
Outperform
Performance Comparison
Ticker
Company Name
Price
Change
% Change
SASS
M.D. Sass Concentrated Value ETF
23.80
-0.89
-3.60%
GMOV
GMO US Value ETF
VUSV
Vanguard Wellington U.S. Value Active ETF
CVAR
Cultivar ETF
GVLE
Goldman Sachs Value Opportunities ETF
USFE
First Eagle US Equity ETF
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents
Advertisement